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Unsubstituted quinoxaline (I) reacts with dimedone, indanedione, and 1-phenyl-3-methylpyrazol-5-one in
dimethylsulfoxide in the presence of acid to form monosubstitution products II – IV. Quinoxaline reacts with
1,3-dimethylbarbituric acid in dimethylsulfoxide solution at room temperature to form monosubstitution
product V without external catalysis. Heating of I with resorcinol in ethanol in the presence of acid produced
resorcinol derivative VI. In the presence of base, quinoxaline reacts with 1-phenyl-3-methylpyrazol-5-one to
form dipyrazolylmethane VII and tetrapyrazolylethane derivative VIII. Compound VIII undergoes cleavage
to form dipyrazolylmethane VII in dimethylformamide solution with boiling or in the presence of iodine at
room temperature.
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Quinoxaline derivatives include compounds with differ-
ent types of biological activity [1, 2]. Quinoxaline deriva-
tives – quinoxidine and dioxidine – are used as antimicrobial
substances [3]. A series of condensed quinoxalines has been
patented as antitumor agents [4].
Substituted quinoxalines are synthesized either by con-
densation of the corresponding substituted o-phenylenedia-
mines with 1,2-dihydroxy derivatives or by substitution reac-
tions in the quinoxaline nucleus. N-alkyl quaternary quin-
oxaline salts react with 1,3-diketones to form di-attachment
or cyclo-attachment products at the C
2
-C
3
bond [5, 6]. At the
same time, the literature contains virtually no data on the
synthesis of products by direct insertion of CH acid residues
into unsubstituted quinoxaline.
We have observed that unsubstituted quinoxaline (I) in-
teracts with 1,3-diketones – indanedione and dimedone – in
the presence of hydrochloric acid in dimethylsulfoxide at
room temperature to form 2-(1,3-dihydroxyindan-2-yli-
dene)-1H-1,2-dihydroquinoxaline (II) and 2-(1,3-dihydro-
xy-5,5-dimethylcyclohexan-2-ylidene)-1H-1,2-dihydroqui-
noxaline (III) respectively (scheme 1). In analogous condi-
tions, I reacts with 1-phenyl-3-methylpyrazol-5-one to yield
2-(1-phenyl-3-methyl-5-oxypyrazol-4-yliden)-1H-1,2-dihy-
droquinoxaline (IV).
It is interesting that 1,3-dimethylbarbituric acid I reacts
in aqueous dimethylsulfoxide at room temperature to form
2-(1,3-dimethyl-2,4,6-trioxy-1,2,3,4,5,6-hexahydropyrimid-
5-yliden)-1H-1,2-dihydroquinoxaline (V) in the absence of
an external catalyst. We first reported this conversion in a re-
cent letter to the editor [7].
Heating with resorcinol in boiling ethanol in the presence
of hydrochloric acid converts I into 2-(2,4-dihydroxyphe-
nyl)quinoxaline (VI).
The molecular weights of compounds II-VI measured by
mass spectrometry were consistent with calculated values. A
characteristic diagnostic property for monosubstitution prod-
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ucts II – VI in the
1
H NMR spectrum was the presence of in-
dividual signals from the pyrazine ring proton at 9.0 –
10.5 ppm.
It is interesting that the reaction of quinoxaline I with C
nucleophiles did not stop at the stage of -adduct formation,
but continued to oxidation of these compounds to aromatic
substitution products.
In a short report, the authors of the present study recently
reported unusual conversions of unsubstituted I with
1-phenyl-3-methylpyrazol-5-one in dimethylsulfoxide in the
presence of base [8]. In fact, the reaction of I with 1-phenyl-
3-methylpyrazol-5-one in the presence of triethylamine
yielded the known dipyridylmethane (VII) [9] and
1,1,2,2-tetra(5-methyl-3-oxo-2-phenyl-1,2-dihydro-3H-pyra
zol-4-yl)ethane (VIII). In addition, preparative thin-layer
chromatography on silica gel was used to isolate o-phenyl-
enediamine IX from the reaction products (scheme 2).
A singlet signal from two equivalent ethane protons in
the PMR spectrum at 4.74 ppm was typical of tetrapyrazolyl
derivative VIII.
The fine structure of product VIII was established by
x-ray structural analysis (Fig. 1) [8].
In the conversion of I with 1-phenyl-3-methylpyrazolol-
5-one in the presence of base, quinoxaline served as a two-
carbon fragment donor. During the reaction, the initially form-
ing tetrapyrazolyl derivative VIII underwent cleavage with
formation of small quantities of dipyrazolylmethane VII.
It should be noted that transient heating of tetrapyrazolyl
derivative VIII in boiling dimethylformamide produced
dipyrazolylmethane VII. Product VIII was also converted
into VII in dimethylformamide in the presence of iodine at
room temperature. The conversion VIII > VII also occurred
on transient heating of crystals of substance to 255 – 260°C.
Thus, these studies revealed a simple means of obtaining
monosubstituted quinoxaline derivatives with formation of
water during substitution of the hydrogen atom, which is of
practical interest in the synthesis of new potentially biologi-
cally active derivatives. It should also be noted that the un-
usual conversions of quinoxaline seen in reactions with
1-phenyl-3-methylpyrazol-5-one may be of interest in study-
ing and understanding metabolic processes involving re-
agents of this type.
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Fig. 1. Molecular structure of compound VIII.
Main bond lengths: N(1)-N(2) 1.3934(17); N(2)-C(8) 1.3617(19); C(8)-C(10) 1.358(2); C(7)-C(10) 1.428(2); N(1)-C(7) 1.3729(18);
N(1)-C(6) 1.419(2); O(1)-C(7) 1.2573(17); N(5)-N(6) 1.3842(17); N(6)-C(30) 1.3680(19); C(32)-C(30) 1.356(2); C(29)-C(32) 1.422(2);
C(29)-N(5) 1.3717(18); N(5)-C(28) 1.4193(19); O(3)-C(29) 1.2632(17); N(3)-N(4) 1.3794(17); N(3)-C(15) 1.3296(18); C(15)-C(13) 1.400(2);
C(13)-C(14) 1.373(2); N(4)-C(14) 1.3570(19); N(4)-C(17) 1.427(2); O(2)-C(14) 1.3302(18); N(8)-N(7) 1.3817(17); N(7)-C(35) 1.3282(19);
C(33)-C(35) 1.407(2); N(8)-C(34) 1.3619(18); N(8)-C(37) 1.4148(19); O(4)-C(34) 1.3374(17).
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EXPERIMENTAL SECTION
NMR spectra were recorded on a DRX-400 spectrometer
(Federal Republic of Germany). Electron impact mass spec-
tra (MS-EI) were obtained on a MicrOTOF-Q instrument
from Bruker Daltonics with a mean ionizing tension of 75 eV
at a temperature of 250°C. Elemental analysis data corre-
sponded to calculated values.
2-(1,3-Dioxoindan-2-yliden)-1H-1,2-dihydroquinoxali
ne (II). Compound I (0.065 g, 0.5 mmol) and indanedione
(0.140 g, 0.98 mmol) were held for 2 h at 20 – 25°C in 2 ml
of dimethylsulfoxide (DMSO) in the presence of 0.05 ml of
concentrated HCl. The reaction mix was filtered and the re-
sulting precipitate was recrystallized from ethanol. The yield
was 0.055 g (40%). Melting temperature was 250°C. The
PMR spectrum (DMSO-d
6
), , ppm, was: 7.58 (t, 1H, J 8.0
Hz, CH
quinoxaline
), 7.70 (s, 4H, CH
indanedione
), 7.74 (t, 1H, J 8.0
Hz, CH
quinoxaline
), 7.93 (s, 1H, CH
quinoxaline
), 8.04 (d, 1H, J 8.0
Hz, CH
quinoxaline
), 9.94 (s, 1H, CH
quinoxaline
), 13.51 (broad s,
1H, OH). The mass spectrum, m/z (I
rel
, %), was: 274 [M
+
]
(100). C
17
H
10
N
2
O
4
.
2-(1,3-Dioxo-5,5-dimethylcyclohexan-2-yliden)-1H-1,2-
dihydroquinoxaline (III). Compound I (0.130 g, 1.0 mmol)
and dimedone (0.160 g, 1.14 mmol) were held for 24 h at
20 – 25°C in 1 ml of DMSO in the presence of 0.1 ml of con-
centrated HCl. The reaction mixture was filtered. The precip-
itate of III was recrystallized form ethanol. The yield was
0.120 g (45%). The melting temperature was 173 – 174°C.
The PMR spectrum (DMSO-d
6
), , ppm, was: 1.07 (s, 6H,
2  CH
3
); 7.67 (t, 1H, J 8.3, CH
quinoxaline
); 7.80 (t, 1H, J 8.3
Hz, CH
quinoxaline
); 7.91 (d, 1H, J 8.3 Hz, CH
quinoxaline
); 8.00
(d, 1H, J 8.3 Hz); 10.29 (s, 1H, CH
quinoxaline
). The mass spec-
trum, m/z (I
rel
, %), was: 263 [M
+
] (73). C
17
H
10
N
2
O
4
.
2-(1-Phenyl-3-methyl-5-oxopyrazol-4-yliden)-1H-1,2-
dihydroquinoxaline (IV). Compound I (0.130 g, 1.0 mmol)
and pyrazolone (0.250 g, 1.44 mmol) were held for 48 h at
20 – 25°C in 1 ml of DMSO in the presence of 0.1 ml of
HCl. The resulting precipitate was collected by filtration and
washed with cold ethanol. The yield was 0.110 g (36%). The
melting temperature was 158 – 160°C.
The PMR spectrum (DMSO-d
6
), , ppm, was: 2.60 (s,
3H, CH
3
), 7.12 – 7.17 (m, 1H, CH
arom
), 7.36 – 7.41 (s, 2H,
CH
arom
), 7.54 – 7.60 (m, 1H, CH
quinoxaline
), 7.71 – 7.76 (m,
1H, CH
quinoxaline
), 7.84 – 7.87 (m, 1H, CH
quinoxaline
),
7.91 – 7.94 (m, 1H, CH
quinoxaline
), 8.01 – 8.04 (m, 2H,
CH
arom
), 9.14 (broad s., 1H, CH CH
quinoxaline
). The mass
spectrum, m/z (I
rel
, %), was: 302 [M
+
] (100). C
18
H
14
N
4
O
2
.
2-(1,3-Dimethyl-2,4,6-trioxo-1,2,3,4,5,6-hexahydropyri-
mid-5-yliden)-1H-1,2-dihydroquiloxaline (V). Compound
I (0.130 g, 1.0 mmol) and 1,3-dimethylbarbituric acid
(0.156 g, 1.0 mmol) were held in 1 ml of DMSO in the pres-
ence of 0.05 ml of H
2
O for 95 – 100 h at 20 – 25°C. The pre-
cipitate was collected by filtration, washed with 5 ml of wa-
ter, and dried. The yield was 0.085 g (30%). The melting
temperature was >250°C. The PMR spectrum (DMSO-d
6
), ,
ppm, was: 3.33 (s, 6H, 2  CH
3
); 7.65 – 7.70 (m, 1H,
CH
quinoxaline
); 7.78 – 7.85 (m, 1H, CH
quinoxaline
); 7.95 – 7.97
(m, 1H, CH
quinoxaline
); 8.02 – 8.06 (m, 1H, CH
quinoxaline
);
10.57 (s, 1H, CH
quinoxaline
); 16.27 (broad s, 1H, NH). The
mass spectrum, m/z (I
rel
, %), was: 284 [M
+
] (100).
C
14
H
12
N
4
O
3
.
2-(2,4-Dihydroxyphenyl)quinoxaline (VI). Compound
I (0.130 g, 1.0 mmol) and resorcinol (0.135 g, 1.2 mmol) in
5 ml of ethanol were boiled for 5 min in the presence of
0.2 ml of concentrated HCl. The reaction mix was diluted 1:1
with water and cooled to a tempo 15 – 20°C. The precipitate
of VI was collected by filtration. The yield was 0.055 g
(25%). The melting temperature was >250°C. The PMR
spectrum (DMSO-d
6
), , ppm, was: 6.35 (d, 1H, J 2.8 Hz,
CH
arom
); 6.42 (dd, 1H, J 8.8, J 2.8 Hz, CH
arom
); 7.68 – 7.74
(m, 1H, CH
quinoxaline
); 7.76 – 7.82 (m, 1H, CH
quinoxaline
);
7.97 – 7.99 (m, 1H, CH
quinoxaline
); 8.00 – 8.03 (m, 1H,
CH
quinoxaline
); 8.07 (d, 1H, J 8.8 Hz, CH
arom
); 9.55 (s, 1H,
CH
quinoxaline
); 9.88 (s, 1H, OH), 13.36 (broad s, 1H, OH). The
mass spectrum, m/z (I
rel
, %), was: 238 [M
+
] (100).
C
14
H
10
N
2
O
2
.
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